Sonavex is a developer of an imaging technology designed to visualize and quantify critical data to detect anastomotic blood clots.
Sonavex is committed to improving outcomes for surgical patients by using cutting-edge imaging technology to provide clinicians with visualization of critical data -- directly at the point of care. The company's technology offers a proprietary technology platform that utilizes ultrasound to detect blood clots after surgery, enabling clinicians to measure critical intravascular flow metrics to detect post-operative clots directly at the point of care and improve outcomes.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 25, 2022 | Grant | $1.70M | 1 | National Institutes of Health | — | Detail |
Aug 29, 2019 | Grant | $3M | 1 | National Institutes of Health | — | Detail |
Mar 9, 2018 | Series A | $1M | 1 | — | — | Detail |
Apr 24, 2017 | Series A | $4.50M | 1 | — | — | Detail |
Sep 6, 2016 | Grant | $1.39M | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Institutes of Health | Yes | Grant |
National Science Foundation | Yes | Grant |
Gaingels | — | Series A |
TEDCO | — | Series A |
BlueJay Syndicate | — | Seed |